Pharmaceutical Policy Publications

Selected Books

Roberts MJ, Reich MR, Pharmaceutical Reform: A Guide to Improving Performance and Equity. Washington, DC: World Bank, 2011. [Download PDF]

Frost LJ, Reich MR, Access: How Do Good Health Technologies Get to Poor People in Poor Countries? Cambridge: Harvard Center for Population and Development Studies, distributed by Harvard University Press, 2008. [Download PDF]

Wirtz V, Leyva Flores R, Reich MR, eds., Política Farmacéutica de México, special issue of Salud Pública de México, 50(suppl 4), 2008. [Link to journal]

Reich MR, ed., Public-Private Partnerships for Public Health. Cambridge: Harvard Center for Population and Development Studies, distributed by Harvard University Press, 2002. [Download PDF]

Reich MR, ed., An Assessment of U.S. Pharmaceutical Donations: Players, Processes, and Products. Boston, MA: Harvard School of Public Health, 1999. [Download PDF]

Reich MR, ed., International Strategies for Tropical Disease Treatments: Experiences with Praziquantel, Geneva: World Health Organization, 1998. [Download PDF]

Brudon-Jakobowicz P, Rainhorn JD, Reich MR, Indicators for Monitoring National Drug Policies: A Practical Manual, Geneva: World Health Organization, 1994. [Download PDF]

Articles and Book Chapters 

Rockers PC, Reich MR, Kettler H, Wirtz VJ, “Commitment to Impact: Strengthening Measurement of Industry-Led Access-to-Medicines Programs,” Health Systems & Reform 4(3): 188-193, 2018. [Click here].

Gray AL, Wirtz VJ, ’t Hoen EFM, Reich MR, Hogerzeil HV, “Essential Medicines are Still Essential,” Lancet 386:1601-1603, 2015.

Manne JM, Snively CS, Ramsey JM, Ocampo Salgado M, Barnighausen T, Reich MR, “Barriers to Treatment Access for Chagas Disease in Mexico,” PLoS Neglected Tropical Diseases 7(10): e2488, 2013. doi:10.1371/journal.pntd.0002488 [Click here]

Raja S, Kippen S, Reich MR, “Improving Access to Psychiatric Medicines in Africa,” in Akyeampong E, Hill A, Kleinman A, eds., Psychiatry in Africa, Bloomington IN: Indiana University Press, 2013.

Gómez-Dantés O, Wirtz VJ, Reich MR, Terrazas P, Ortiz M, “A New Entity for the Negotiation of Public Procurement Prices for Patented Medicines in Mexico,” Bulletin of the World Health Organization 90: 788-792, 2012. [Download PDF]

Manne J, Snively CS, Levy MZ, Reich MR, “Supply Chain Problems for Chagas Disease Treatment,” Lancet Infectious Diseases 12: 173-175, 2012. [Download PDF]

Goroff M, Reich MR, “Partnerships to Provide Care and Medicine for Chronic Diseases: A Model for Emerging Markets,” Health Affairs 29: 2206-2213, 2010. [Download PDF]

Reich MR, “Foreword,” in Eggleston K, ed., Prescribing Cultures and Pharmaceutical Policy in the Asia-Pacific, Palo Alto, CA: Walter H. Shorenstein Asia-Pacific Research Center, Stanford University, 2009, pp. xi-xiv. [Download PDF]

Villa S, Compagni A, Reich MR, “Orphan Drug Legislation: Lessons for Neglected Tropical Diseases,” International Journal of Health Planning and Management, 2008. [Download PDF]

Wirtz V, Reich MR, Leyva R, Dreser A, “Medicines in Mexico 1990-2004: Review of Research on Use, Access and Quality,” Salud Pública de México 50(suppl 4): S470-S479, 2008. [Download PDF]

Wirtz VJ, Reich MR, Hernández-Avila M, “Editorial: Investigación Para Sustentar Políticas Farmacéuticas,” Salud Pública de México 50(suppl 4):S427-428, 2008.

Grépin KA, Reich MR, “Conceptualizing Integration:A Framework for Analysis Applied to Neglected Tropical Disease Control Partnerships,” PLoS Neglected Tropical Diseases 2(4):e174, 2008. [Download PDF]

Hodgkin C, Molyneux DH, Abiose A, Philippon B, Reich MR, et al, “The Future of Onchocerciasis Control in Africa,” PLoS Neglected Tropical Diseases 1(1):e74, 2007. [Download PDF]

Ramiah I, Reich MR, “Building Effective Public-Private Partnerships: Experiences and Lessons from the African Comprehensive HIV/AIDS Partnerships (ACHAP),” Social Science & Medicine 63:397-408, 2006. [Download PDF]

Leyva R, Wirtz V, Dreser A, Reich M, “Reseña: Hacia una política farmacéutica integral para México,” Salud Pública de México 48(2):179-810, 2006.

Wirtz V, Leyva R, Dreser A, Ángeles A, Reich M, “Observaciones sobre la Propuesta de la Nueva Política de Medicamentos en México,” Boletín Fármacos 8(5):56-58, 2005.

Kwon S, Reich MR, “The Changing Process and Politics of Health Policy in Korea,” Journal of Health Politics, Policy and Law 30(6): 1003-1025, 2005. [Download PDF]

Reich MR, Bery P, “Expanding Global Access to ARVs: The Challenges of Prices and Patents,” in Mayer KH, Pizer HF, eds., The AIDS Pandemic: Impact on Science and Society, New York: Academic Press, 2005, pp. 324-350. [Download PDF]

Ramiah I, Reich MR, “Public-Private Partnerships and Antiretroviral Drugs for HIV/AIDS: Lessons from Botswana,” Health Affairs 24(2): 545-551, 2005. [Download PDF]

Frost L, Reich MR, Fujisaki T, “A Partnership for Ivermectin: Social Worlds and Boundary Objects,” in Reich MR, ed., Public-Private Partnerships for Public Health, Cambridge, MA: Harvard Center for Population and Development Studies, distributed by Harvard University Press, 2002, pp. 87-113.

Reich MR, “The Global Drug Gap,” Science 287:1979-1981, 2000. [Download PDF]

Reich MR, “Public-Private Partnerships for Public Health,” Nature Medicine 6(6):617-620, 2000.

Reich MR, Wagner AK, McLaughlin TJ, Dumbaugh KA, Derai-Cochin M, “Pharmaceutical Donations by the USA: An Assessment of Relevance and Time-to-Expiry,” Bulletin of the World Health Organization 77(8):675-680, 1999. [Download PDF]

Reich MR, “Sachs and Drugs,” Letter to the Editor, The Economist, September 4, 1999, p. 12.

Goto A, Reich MR, and Aitken I, “Oral Contraceptives and Women’s Health in Japan,” Journal of the American Medical Association, 282(2):2173-2177, 1999. [Download PDF]

Reich MR, Govindaraj R, “Dilemmas in Drug Development for Tropical Diseases: Experiences with Praziquantel,” Health Policy 44(1):1-18, 1998. [Download PDF]

Zuber PLF, Mann JM, Paccaud F, Reich MR, Turoff M, “Introducing a First AIDS Vaccine in Switzerland: A Policy Delphi Analysis,” Soz. Präventivmed 41:126-127, 1996.

Moriga M, Ikeda S, Reich MR, “An Analysis of Pharmacoeconomic Studies in Japan,” Iryo Keizai Kenkyu (Health Economics Research) 2:71-81, 1995.

Reich MR, “The Politics of Health Reform in Developing Countries: Three Cases of Pharmaceutical Policy,” Health Policy 32:47-77, 1995. [Download PDF]

Rainhorn JD, Brudon-Jakobowicz P, Reich MR, “Priorities for Pharmaceutical Policies in Developing Countries: Results of a Delphi Survey,” Bulletin of the World Health Organization 72(2):257-264, 1994. [Download PDF]

Reich MR, “Bangladesh Pharmaceutical Policy and Politics,” Health Policy and Planning 9(2):130-143, 1994. [Download PDF]

Hawkins ES, Reich MR, “Japanese-originated Pharmaceutical Products in the United States from 1960 to 1989: An Assessment of Innovation,” Journal of Clinical Pharmacology & Therapeutics 51(1):1-11, 1992.

Arnold PJ, Reich MR, “PVO Pharmaceutical Donations: Making the Incentive Fit the Need,” Journal of Research in Pharmaceutical Economics 2(4):49-70, 1991.

Reich MR, “Why the Japanese Don’t Export More Pharmaceuticals: Health Policy as Industrial Policy,” California Management Review 32(2):124-150, 1990. [Download PDF]

Reich MR, “Technical Fixes and Other Problems in Saving Lives in the World’s Poorest Countries,” Journal of Public Health Policy 9(1):92-103, 1988.

Reich MR, “Essential Drugs: Economics and Politics in International Health,” Health Policy 8:39-57, 1987. [Download PDF]